Skip to main content
Smart Investors Daily
Bullfrog AI Holdings, Inc. Common Stock logo

NASDAQ · BFRG

Bullfrog AI Holdings, Inc. Common Stock

Healthcare · Medical - Healthcare Information Services

$0.59

Up+$0.10 (+15.99%)

Updated Oct 6, 2026, 9:41 PM

SID Score

4.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
11.08M
P/E ratio
-1.76
Dividend yield
0.00%
52-week range
$0.43 – $1.96
Volume
537.92K
Avg. volume
228.81K

Price performance · BFRG

BFRG price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 5, 2026

BFRG closed at $0.59 after 20 trading sessions, up 23.24% for the selected period.

Last close
$0.59
Period change
+23.24%
Period low
$0.43
Period high
$0.95
Daily close
View OHLC price history
BFRG OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 5, 2026$0.6045$0.6299$0.5801$0.594537.92K
Oct 2, 2026$0.63$0.63$0.58$0.6175428.11K
Oct 1, 2026$0.6081$0.6299$0.5901$0.6283311.61K
Sep 30, 2026$0.62$0.6543$0.60$0.6012335.71K
Sep 29, 2026$0.63$0.6544$0.6141$0.6479307.25K
Sep 28, 2026$0.6733$0.6769$0.5877$0.6565850.33K
Sep 25, 2026$0.7695$0.8785$0.6521$0.66563M
Sep 24, 2026$0.8145$0.8424$0.6626$0.76475.22M
Sep 23, 2026$0.7816$1.05$0.705$0.95191.73M
Sep 22, 2026$0.53$0.8198$0.4402$0.6068.65M
Sep 21, 2026$0.4696$0.50$0.4696$0.493218.17K
Sep 18, 2026$0.454$0.469$0.4359$0.463869.06K
Sep 17, 2026$0.43$0.47$0.43$0.468175.81K
Sep 16, 2026$0.441$0.441$0.4255$0.428594.73K
Sep 15, 2026$0.48$0.48$0.4401$0.448387.13K
Sep 14, 2026$0.4693$0.489$0.4659$0.471287.99K
Sep 11, 2026$0.48$0.50$0.4607$0.475965.94K
Sep 10, 2026$0.4789$0.51$0.4732$0.4855138.4K
Sep 9, 2026$0.492$0.4931$0.4785$0.49274.91K
Sep 8, 2026$0.48$0.5109$0.48$0.48286.85K

Latest BFRG news

The latest Smart Investors Daily articles mentioning BFRG.

BFRG research

Overview

Company profile and research snapshot.

Company profile

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.